Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04938804 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-risk Based Lang Cancer Screening With a One-off LDCT

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 9, 2024 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 1 to 2v4 Show 5 more changesShow less
    • Start date: Dec 1, 2015 to Dec 12, 2015
    • Eligibility criteria expanded, about 20 words
    • Secondary endpoints: 4 to 2
    • Study description expanded, about 111 words
    • Study title shortened, about 1 word
  2. Eligibility criteria shortened, about 26 wordsv3
  3. Eligibility criteria shortened, about 17 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Guangzhou Lung-Care Project is a single-arm, prospective cohort study using one-time low-dose computed tomography for the early detection of LC, recruiting residents aged 40-74 years from four communities in Guangzhou between 2015 and 2021.The primary outcome was LC detection rate in eligible participants without restrictions based on high-risk factors and the proportion of stage I LC cases, and to investigate the various factors associated with the development of LC.
Trial Details
NCT Number NCT04938804
Lead Sponsor The First Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Lung Cancer
Related terms Lung Neoplasms
Enrollment 11,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov